+13.1%
GSK vs TSN
+19.9%
-6.8%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | TSN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +5.4% | -0.4% | +3.9% |
| 7D | +4.9% | +8.4% | -3.5% | +3.3% |
| 30D | +9.9% | +16.1% | -6.2% | +7.0% |
| 3M | +0.2% | +3.2% | -3.0% | -0.5% |
| 6M | +2.3% | -11.1% | +13.5% | +4.1% |
| YTD | +7.1% | +5.1% | +2.0% | +6.8% |
| 1Y | +13.1% | +19.4% | -6.3% | +11.7% |
| All | +13.1% | +19.9% | -6.8% | +11.7% |
Cumulative growth
Daily Returns
Daily percentage return beside TSN.
Daily Out/Under-Performance
Portfolio return minus TSN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TSN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded TSN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling